Navigation Links
Aires Pharmaceuticals Appoints Edwin L. Parsley as Chief Medical Officer
Date:5/4/2011

SAN DIEGO, May 4, 2011 /PRNewswire/ -- Aires Pharmaceuticals, Inc. today announced the hiring of Ed Parsley, D.O. as Chief Medical Officer.  Dr. Parsley will fill a key role on Aires' leadership team and will be responsible for all clinical development activities for Aironite™, the company's lead product for treatment of pulmonary arterial hypertension (PAH).

Dr. Parsley joins Aires from Pfizer where he was the Clinical Lead for ongoing clinical trials for Revatio (Sildenafil), Pfizer's approved drug to treat PAH, as well as the additional compounds in Pfizer's pulmonary vascular disease portfolio.  Dr. Parsley previously worked at CSL Biotherapies and Encysive Pharmaceuticals, Inc. where he was the Executive Director for Global Medical Affairs and Drug Safety developing an endothelin antagonist for pulmonary hypertension, heart failure and resistant hypertension.

Dr. Parsley is a practicing physician and Board certified in Pulmonary, Internal Medicine, Critical Care and Sleep Medicine.  Prior to joining industry, he was an assistant professor and medical director at the University of Texas Medical School at Houston.

"We are excited to welcome Ed to our team," stated Wendy Johnson, President & CEO of Aires.  "Ed brings a wealth of experience developing drugs for treatment of PAH and other pulmonary vascular diseases.  He is well-known in the PAH community and will make immediate contributions to shaping and executing our clinical development program."

About Aires

Aires Pharmaceuticals, Inc. is a privately held drug development company located in San Diego developing Aironite™ for cardiopulmonary indications such as pulmonary arterial hypertension.  In November 2010, Aires announced a $20M equity financing funded by ProQuest Investments and MPM Capital.


'/>"/>
SOURCE Aires Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. T-System Provides Free Medical Documentation Templates and Bi-Lingual Triage Questionnaires for Haiti Relief Medical Personnel
2. Buenos Aires Welcomes CPhI South America 2010
3. Aires Pharmaceuticals, Inc. Completes $20M Equity Financing and Signs an Option Agreement with a Major Pharmaceutical Company
4. CardioGenics Requests Stockholders to Participate in Stockholder Questionnaires
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2017)... MINNEAPOLIS , July 5, 2017 Pace Analytical, a company of ... announcing today that they have acquired ESC Lab Sciences, further solidifying their position ... the United States . ... Steve Vanderboom- President and CEO of Pace Analytical ... of ESC Lab Sciences out of Mt Juliet, TN , ...
(Date:6/30/2017)... , June 30, 2017  AVACEN Medical (AVACEN) announced the ... The research describes the use of its AVACEN Treatment Method ... suffering from fibromyalgia. ... AVACEN Medical ... characterized by chronic widespread pain. It affects approximately 200 to 400 million ...
(Date:6/20/2017)... HILLS, Calif. , June 20, 2017 SkylineDx ... the use of MMprofiler with SKY92, the company,s prognostic ... In a poster presentation at the 22 nd ... Madrid, Spain , SkylineDx researchers will demonstrate ... patients. In a separate e-poster presentation ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... , ... ChenMed , a leading provider of value-based care for seniors, ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine ... Ambulatory Services for the UVA Health System, brings 30 years of highly relevant experience ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... a telemedicine platform, in which their iMedSecure™ comes included with each system installation. ... encrypted live images to remote participants for real-time collaboration and immediate decision-making requirements. ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... FDAnews Webinar**, Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, ... inspections and boosting quality. , It’s known as the “CY2016 Annual FDA Medical ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... protection services since 2014, top travel insurance solution company VisitorsCoverage Inc. has launched ... sell all major international travel insurance products online, under their own brand. The ...
(Date:7/20/2017)... ... 19, 2017 , ... At Creekwood Dental Arts, Drs. Donna G. Miller and ... dental implants in Waco, TX, using the latest dental technology for digital ... they can capture details in the oral cavity for accurate diagnoses and customized care ...
Breaking Medicine News(10 mins):